Press Release

Back
WellPoint Reports Results for Fourth Quarter and Full Year 2006

Click here for printer-friendly version

  • Fourth quarter net income was $1.28 per share, which included net realized investment gains of $0.01 per share
  • Selling, general and administrative expense ratio continued to improve, declining by 100 basis points from fourth quarter of 2005
  • Full year 2006 net income was $4.82 per share, an increase of 22% from 2005
  • Operating cash flow was strong in 2006, exceeding $4.0 billion or 1.3 times net income
  • Company expects 1.4 million new members and net income of $5.53 per share in 2007

INDIANAPOLIS, Jan. 24 /PRNewswire-FirstCall/ -- WellPoint, Inc. (NYSE: WLP) today announced that fourth quarter 2006 net income was $801.1 million, or $1.28 per share. These results included $0.01 per share in net realized investment gains. Net income in the fourth quarter of 2005 was $652.0 million, or $1.04 per share, including $0.01 per share in net realized investment losses.

Full year 2006 net income was $4.82 per share, including $0.04 per share in tax benefits resulting from a change in state tax apportionment factors following the WellChoice acquisition. Net income for the full year of 2005 was $3.94 per share. The 2005 results included expenses of $0.10 per share due to the multi-district settlement agreement and net realized investment losses of $0.01 per share, partially offset by benefits of $0.04 per share for the favorable resolution of a tax matter relating to the sale of certain subsidiaries in the mid-1990s.

"Throughout 2006, we introduced a number of new products and services that were focused on improving the health of our members, enhancing quality, and providing more options to meet the diverse needs of consumers across the country," said Larry C. Glasscock, chairman, president and chief executive officer of WellPoint, Inc. "We achieved continued strong growth in our National Accounts business, successfully introduced Medicare Part D products, with enrollment reaching 1.6 million members by year-end, and won five new state contracts to manage approximately 500,000 Medicaid managed care lives. We are well positioned for future growth with an array of innovative products and services that engage the consumer and promote the delivery of affordable, quality health care, including 360 degree Health, an innovative integrated health, well-being, and medical management program, and Lumenos Consumer Driven Health Plans ("CDHP")."

"Our financial performance for 2006 was very strong, led by earnings per share growth of 22 percent for the year," said David C. Colby, executive vice president and chief financial officer of WellPoint, Inc. "We continued to price our products with discipline and significantly reduce administrative costs as a percentage of total revenue. Earnings quality was high, as evidenced by operating cash flow in excess of $4.0 billion, or 130 percent of net income. We also continued our share buy-back program, repurchasing nearly $4.6 billion, or 9.2 percent, of our outstanding shares during 2006. We will continue to deploy our cash flow in a manner that strengthens operations and enhances shareholder value in 2007, and expect to return excess capital to our shareholders through our share repurchase program."

COMPARABLE BASIS INFORMATION

On December 28, 2005, WellPoint, Inc. acquired WellChoice, Inc. For accounting purposes, the transaction was assumed to have closed on December 31, 2005. Accordingly, operations of the former WellChoice, Inc. are included in reported financial results for the periods ended in 2006. However, operations of the former WellChoice, Inc. are not included in reported financial results for the periods ended in 2005.

Unless otherwise indicated, the analysis in this press release compares reported financial results and does not adjust results for the effects of this acquisition. In certain areas, we have included "comparable basis" analyses that we believe provide more meaningful comparisons between periods, due to the inclusion of operations of the former WellChoice, Inc. in the comparable historical results. The "comparable basis" information is not calculated in accordance with U.S. generally accepted accounting principles ("GAAP") and is not intended to represent or be indicative of the results that WellPoint, Inc. would have reported had the acquisition been completed as of the beginning of the periods presented, and should not be taken as representative or indicative of our future results. The methodologies for calculating the comparable basis information are either described within the text of the press release, or in the tables at the end of the press release where such comparable basis information is reconciled to WellPoint, Inc.'s reported GAAP financial results.

CONSOLIDATED HIGHLIGHTS

Membership: Medical enrollment totaled 34.1 million members at December 31, 2006. During the quarter, the Company's ownership of a joint venture in Puerto Rico changed from a 50 percent ownership of a Medicaid managed care subsidiary to a smaller percentage ownership in the joint venture's parent company. Accordingly, the Company will no longer include the 222,000 members related to this investment in its reported enrollment, but will continue to receive financial benefits from these members, along with the commercial and Medicare members of the joint venture's parent company.

Excluding the impact of this 222,000 member accounting adjustment, the Company's membership increased by 467,000 members, or 1.4 percent, from the prior year. This increase was driven by the National Accounts business which added 632,000 members during the year, representing growth of 7.3 percent. Partially offsetting the strong performance in National Accounts was a decline of 348,000 members in the Large Group business resulting from the previously- announced losses of three large groups totaling approximately 444,000 members.

Operating Revenue: Operating revenue was $14.3 billion in the fourth quarter of 2006, an increase of 28.7 percent from $11.1 billion in the prior year quarter.

On a comparable basis, fourth quarter 2006 operating revenue increased by $1.5 billion, or 12.0 percent, versus $12.8 billion in the prior year period. The increase resulted primarily from disciplined pricing, enrollment in the Company's Medicare Part D products, the addition of the New York state prescription drug contract in 2006, and increased reimbursement in the Federal Employee Program ("FEP").

Benefit Expense Ratio: The benefit expense ratio was 81.1 percent in the fourth quarter of 2006, a 140 basis point increase compared with 79.7 percent in the fourth quarter of 2005.

On a comparable basis, the benefit expense ratio increased by 50 basis points, from 80.6 percent in the fourth quarter of 2005. The ratio increased from the prior year due to growth in businesses with benefit expense ratios higher than the Company average, including the New York state prescription drug contract, FEP business (for which the Company is reimbursed for its costs plus a fee), Medicare Advantage plans, and State Sponsored programs. The impact of this shift in business mix was partially offset by other items, including Medicare Part D performance in the quarter.

Sequentially, the benefit expense ratio decreased by 20 basis points from 81.3 percent in the third quarter of 2006. The decrease was primarily due to seasonality, as the lower Medicare Part D benefit expense ratio was partially offset by higher medical claims resulting from more members reaching their deductibles towards the end of the calendar year. The benefit expense ratio did not decline as much as expected because the reduction in the Medicare Part D benefit expense ratio was smaller than expected due to liabilities incurred as a result of the CMS reconciliation process such as payments owed to state Medicaid programs offset by low income subsidy payments. Also during the quarter, the claims experience in FEP did not decline as much as anticipated and in three states the Company began Medicaid operations more quickly than expected. Medicaid programs typically experience a benefit expense ratio higher than the Company average.

Premium and Cost Trends: Trends include Large Group and ISG fully-insured businesses.

For the rolling 12-month period ended December 31, 2006, the primary drivers of medical trend were inpatient and outpatient costs. Full year 2006 medical cost trend was less than 8 percent, and the Company expects that full year 2007 medical cost trend will remain relatively flat at less than 8 percent. The Company continues to price its commercial business so that premium yield exceeds total cost trend, where total cost trend includes medical costs and selling, general and administrative ("SG&A") expense.

SG&A Expense Ratio: The SG&A expense ratio was 15.7 percent in the fourth quarter of 2006, a decrease of 100 basis points from 16.7 percent in the fourth quarter of 2005. The current quarter included costs for expensing stock options in accordance with FAS 123R, which added 20 basis points to the SG&A ratio, and 10 basis points of severance costs associated with the recent reorganization.

On a comparable basis, the SG&A expense ratio declined by 110 basis points, compared with 16.8 percent in the fourth quarter of 2005. The ratio improved significantly year-over-year as the Company continued to control spending, spread administrative expenses across a growing revenue base, and realize integration synergies and efficiencies.

The SG&A expense ratio increased by 20 basis points compared with 15.5 percent in the third quarter of 2006. The increase primarily resulted from expenses relating to 2007 enrollment preparations, including investment in the Lumenos CDHP nationwide rollout, increased advertising for the Senior business open enrollment period, and the reorganization-related severance costs.

Operating Cash Flow: For the year ended December 31, 2006, operating cash flow totaled $4.0 billion, or 1.3 times net income. In the fourth quarter, operating cash flow totaled $1.4 billion or 1.8 times net income, which included payment of $209.5 million in previously-expensed settlement costs relating to the multi-district litigation.

Days in Claims Payable: Days in claims payable as of December 31, 2006, was 45.2 days, a decrease of 0.4 days from 45.6 days as of September 30, 2006. This decline was primarily attributed to a reduction in the length of time between the date of service and claim payment, and the timing of payments in the pharmacy benefit management ("PBM") operation.

Share Repurchase Program: During the fourth quarter 2006, the Company repurchased 7.3 million shares of its common stock for $550.2 million. For the full year of 2006, the Company repurchased 60.7 million shares for nearly $4.6 billion. As of December 31, 2006, the Company's remaining Board-approved share repurchase authorization was $949.8 million. The Company intends to utilize this authorization during early 2007, subject to market conditions. At December 31, 2006, cash and investments held at the parent company and available for general corporate use totaled approximately $1.7 billion.

REPORTABLE SEGMENTS

At December 31, 2006, WellPoint, Inc. had three reportable segments: Health Care, Specialty, and Other. Operating revenue and operating gain are the key measures used by management to evaluate performance in each segment.


                               WellPoint, Inc.
                        Reportable Segment Highlights
                                 (Unaudited)

    (In millions)   Three Months Ended December 31   Year Ended December 31
                      2006       2005     Change    2006       2005     Change
    Operating Revenue
      Health Care  $13,766.6  $10,615.6   29.7%  $53,860.6  $41,867.0   28.6%
      Specialty        928.9      793.8   17.0%    3,566.2    3,066.1   16.3%
      Other:
        External
         Customers     108.5       76.4   42.0%      454.6      333.6   36.3%
        Intercompany
         Eliminations (484.9)    (361.8) (34.0%)  (1,806.8)  (1,348.3) (34.0%)
      Total Other     (376.4)    (285.4) (31.9%)  (1,352.2)  (1,014.7) (33.3%)
    Total Operating
     Revenue        14,319.1   11,124.0   28.7%   56,074.6   43,918.4   27.7%

    Operating Gain
     (Loss)
      Health Care   $1,097.9     $878.5   25.0%   $4,288.3   $3,418.0   25.5%
      Specialty        143.2      132.8    7.8%      523.6      426.4   22.8%
      Other            (19.4)     (20.0)   3.0%      (75.0)    (111.9)  33.0%

Health Care: Operating gain for the Health Care segment was approximately $1.1 billion in the fourth quarter of 2006, an increase of 25.0 percent, compared with $878.5 million in the fourth quarter of 2005.

On a comparable basis, fourth quarter 2006 operating gain increased by $143.0 million, or 15.0 percent, compared with $954.9 million in the prior year quarter. Performance in the Health Care segment improved year-over-year due to disciplined pricing and underwriting, enrollment in the Company's Medicare Part D products, and continued SG&A expense control. Operating gain in the fourth quarter of 2006 included costs of $33.4 million for expensing stock options in accordance with FAS 123R and $15.9 million of net severance costs related to the recent reorganization.

Specialty: Operating gain for the Specialty segment totaled $143.2 million in the fourth quarter of 2006, an increase of 7.8 percent compared with $132.8 million in the fourth quarter of 2005 on both a reported and comparable basis. The increase resulted primarily from higher prescription volume in the Company's PBM business with the addition of Medicare Part D and better overall generic mix in the mail-order operation. These increases in operating gain were partially offset by higher Vision claims expense, as favorable development in the fourth quarter of 2005 did not recur in the fourth quarter of 2006, and the sale of the Company's at-risk Workers' Compensation business at the end of 2005.

OUTLOOK

Full Year 2007:

  • The Company continues to expect net income of $5.53 per share.
  • Operating revenue is expected to total approximately $61.9 billion.
  • The benefit expense ratio is expected to be approximately 81.5 percent.
  • The SG&A expense ratio is expected to be approximately 14.6 percent.
  • Operating cash flow is now expected to be at least $4.4 billion, or 1.3 times net income.
  • Year-end medical enrollment is expected to be approximately 35.5 million members, representing growth for the year of 1.4 million members, or 4 percent.

First Quarter 2007:

  • The Company continues to expect net income of $1.25 per share.

Basis of Presentation

  1. Operating gain is defined as operating revenue less benefit expense, selling expense, general and administrative expense, and cost of drugs. Operating gain is used to analyze profit or loss on a segment basis. Consolidated operating gain is a non-GAAP measure.
  2. On December 28, 2005, WellPoint, Inc. acquired WellChoice, Inc. Accordingly, operations of the former WellChoice, Inc. are included in reported financial results for the periods ended in 2006. However, operations of the former WellChoice, Inc. are not included in reported financial results for the periods ended in 2005.
  3. Amounts for 2005 and prior do not include the impact of expensing stock options in accordance with FAS 123R. The Company's 2006 reported results and its outlook for 2007, however, do include this impact.
  4. The Company expects to revise its reportable segments and customer types in the first quarter of 2007 in accordance with the new organizational structure, which reflects how management makes business decisions beginning January 1, 2007.
  5. Certain prior period amounts have been reclassified to conform to current period presentation.

Conference Call and Webcast

Management will host a conference call and webcast today at 8:30 a.m. Eastern Standard Time ("EST") to discuss its fourth quarter earnings results. The conference call should be accessed at least 15 minutes prior to the start of the call with the following numbers:

888-423-3268 (Domestic) 800-475-6701 (Domestic Replay)

651-291-5254 (International) 320-365-3844 (International Replay)

An access code is not required for today's conference call. The access code for the replay is 850122. The replay will be available from 1:45 p.m. EST today until the end of the day on February 7, 2007. The call will also be available through a live webcast at www.wellpoint.com under "Investor Info." A webcast replay will be available following the call.

About WellPoint, Inc.

WellPoint's mission is to improve the lives of the people it serves and the health of its communities. WellPoint, Inc. is the largest health benefits company in terms of commercial membership in the United States. Through its nationwide networks, the company delivers a number of leading health benefit solutions through a broad portfolio of integrated health care plans and related services, along with a wide range of specialty products such as life and disability insurance benefits, pharmacy benefit management, dental, vision, behavioral health benefit services, as well as long term care insurance and flexible spending accounts. Headquartered in Indianapolis, Indiana, WellPoint is an independent licensee of the Blue Cross and Blue Shield Association and serves its members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as Blue Cross Blue Shield in 10 New York City metropolitan and surrounding counties and as Blue Cross or Blue Cross Blue Shield in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and through UniCare. Additional information about WellPoint is available at www.wellpoint.com.

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

This press release contains certain forward-looking information about WellPoint, Inc. ("WellPoint") that is intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. Words such as "expect(s)", "feel(s)", "believe(s)", "will", "may", "anticipate(s)" and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to, financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond the control of WellPoint, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include: those discussed and identified in public filings with the U.S. Securities and Exchange Commission ("SEC") made by WellPoint; trends in health care costs and utilization rates; our ability to secure sufficient premium rate increases; competitor pricing below market trends of increasing costs; increased government regulation of health benefits, managed care and pharmacy benefit management operations; risks and uncertainties regarding the Medicare Part D Prescription Drug benefits program, including potential uncollectability of receivables resulting from processing and/or verifying enrollment (including facilitated enrollment), inadequacy of underwriting assumptions, inability to receive and process information, uncollectability of premium from members, increased pharmaceutical costs, and the underlying seasonality of the business; significant acquisitions or divestitures by major competitors; introduction and utilization of new prescription drugs and technology; a downgrade in our financial strength ratings; litigation and investigations targeted at health benefits companies and our ability to resolve litigation and investigations within estimates; our ability to contract with providers consistent with past practice; other potential uses of cash in the future that present attractive alternatives to share repurchases; our ability to achieve expected synergies and operating efficiencies in the WellChoice, Inc. acquisition within the expected time frames or at all, and to successfully integrate our operations; our ability to meet expectations regarding repurchases of shares of our common stock; future bio-terrorist activity or other potential public health epidemics; and general economic downturns. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. WellPoint does not undertake any obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Readers are also urged to carefully review and consider the various disclosures in WellPoint's various SEC reports, including but not limited to WellPoint's Annual Report on Form 10-K for the year ended December 31, 2005, and its Quarterly Reports on Form 10-Q for the reporting periods of 2006.



                                 WellPoint, Inc.
                  Medical Membership & Specialty Metrics Summary
                           (Unaudited and in Thousands)

                                                               Change from
                                Dec. 31, Dec. 31, Sept. 30, Dec. 31, Sept. 30,
    Medical Membership            2006     2005      2006     2005     2006
    Customer Type
    Large Group                  16,014   16,362    15,926    (2.1%)    0.6%
    Individual and Small Group    5,654    5,645     5,651     0.2%     0.1%

       National Accounts          5,044    4,776     5,144     5.6%    (1.9%)
       BlueCard                   4,279    3,915     4,214     9.3%     1.5%
    Total National                9,323    8,691     9,358     7.3%    (0.4%)

    Senior                        1,229    1,224     1,231     0.4%    (0.2%)
    State Sponsored (1)           1,881    1,934     2,024    (2.7%)   (7.1%)
    Total                        34,101   33,856    34,190     0.7%    (0.3%)

    Funding Arrangement
    Self-Funded (1)              16,745   16,584    16,937     1.0%    (1.1%)
    Fully-Insured                17,356   17,272    17,253     0.5%     0.6%
    Total                        34,101   33,856    34,190     0.7%    (0.3%)

    Regional Membership
    East                         13,879   13,800    13,776     0.6%     0.7%
    Central (1)                  10,907   10,970    11,121    (0.6%)   (1.9%)
    West                          9,315    9,086     9,293     2.5%     0.2%
    Total                        34,101   33,856    34,190     0.7%    (0.3%)

    Specialty Metrics
    PBM Prescription Volume (2)  95,685   91,804    90,308     4.2%     6.0%
    Behavioral Health
     Membership                  16,937   15,669    16,048     8.1%     5.5%
    Life and Disability
     Membership                   5,970    5,826     5,956     2.5%     0.2%
    Dental Membership             5,270    5,195     5,193     1.4%     1.5%
    Medicare Part D
     Membership (3)               1,568      -       1,569      -      (0.1%)
    Vision Membership             1,536      816     1,255    88.2%    22.4%


    (1) During the quarter, the Company's ownership of a joint venture in
        Puerto Rico changed from a 50 percent ownership of a Medicaid managed
        care subsidiary to a smaller percentage ownership in the joint
        venture's parent company.  Accordingly, the Company will no longer
        include the 222,000 members related to this investment in its reported
        enrollment.

    (2) Represents quarterly prescription volume at the Company's PBM
        operation.

    (3) Includes auto-assigned, stand-alone, Medicare Advantage, group waiver
        and external PBM members with the prescription drug plan benefit.



                                WellPoint, Inc.
                       Consolidated Statements of Income
                                  (Unaudited)

                                            Three Months Ended
    (In millions, except per share data)       December 31
                                             2006        2005     Change
    Revenues
    Premiums                               $13,293.9   $10,285.2   29.3%
    Administrative fees                        880.7       705.4   24.9%
    Other revenue                              144.5       133.4    8.3%
        Total operating revenue             14,319.1    11,124.0   28.7%
    Net investment income                      225.3       179.9   25.2%
    Net realized gains (losses) on
     investments                                11.1       (11.6)    -
    Total revenues                          14,555.5    11,292.3   28.9%

    Expenses
    Benefit expense                         10,774.9     8,200.3   31.4%
    Selling, general and administrative
     expense
        Selling expense                        424.2       376.5   12.7%
        General and administrative expense   1,830.1     1,486.4   23.1%
            Total selling, general and
             administrative expense          2,254.3     1,862.9   21.0%
    Cost of drugs                               68.2        69.5   (1.9%)
    Interest expense                           100.0        58.0   72.4%
    Amortization of other intangible assets     74.3        60.2   23.4%
    Total expenses                          13,271.7    10,250.9   29.5%

    Income before income taxes               1,283.8     1,041.4   23.3%

    Income taxes                               482.7       389.4   24.0%

    Net income                                $801.1      $652.0   22.9%

    Net income per diluted share               $1.28       $1.04   23.1%

    Diluted shares                             627.0       629.1   (0.3%)

    Benefit expense as a percentage of
     premiums                                  81.1%       79.7%     140 bp
    Selling, general and administrative
     expense as a percentage of total
     operating revenue                         15.7%       16.7%    (100)bp
    Income before income taxes as a
     percentage of total revenues               8.8%        9.2%     (40)bp



                                 WellPoint, Inc.
                        Consolidated Statements of Income

                                                Year Ended
                                                December 31
    (In millions, except per share data)     2006        2005     Change
                                         (Unaudited)
    Revenues
    Premiums                               $51,971.9   $40,680.0    27.8%
    Administrative fees                      3,509.6     2,719.2    29.1%
    Other revenue                              593.1       519.2    14.2%
        Total operating revenue             56,074.6    43,918.4    27.7%
    Net investment income                      878.7       633.1    38.8%
    Net realized losses on investments          (0.3)      (10.2)  (97.1%)
    Total revenues                          56,953.0    44,541.3    27.9%

    Expenses
    Benefit expense                         42,218.8    32,625.2    29.4%
    Selling, general and administrative
     expense
        Selling expense                      1,654.5     1,474.2    12.2%
        General and administrative expense   7,163.2     5,798.5    23.5%
            Total selling, general and
             administrative expense          8,817.7     7,272.7    21.2%
    Cost of drugs                              301.2       288.0     4.6%
    Interest expense                           403.5       226.2    78.4%
    Amortization of other intangible
     assets                                    297.4       238.9    24.5%
    Total expenses                          52,038.6    40,651.0    28.0%

    Income before income taxes               4,914.4     3,890.3    26.3%

    Income taxes                             1,819.5     1,426.5    27.5%

    Net income                              $3,094.9    $2,463.8    25.6%

    Net income per diluted share               $4.82       $3.94    22.3%

    Diluted shares                             642.1       625.8     2.6%

    Benefit expense as a percentage of
     premiums                                  81.2%       80.2%      100 bp
    Selling, general and administrative
     expense as a percentage of total
     operating revenue                         15.7%       16.6%      (90)bp
    Income before income taxes as a
     percentage of total revenues               8.6%        8.7%      (10)bp



                                 WellPoint, Inc.
                           Consolidated Balance Sheets

                                              December 31,      December 31,
    (In millions)                                 2006              2005
                                              (Unaudited)
    Assets
    Current assets:
       Cash and cash equivalents                  $2,602.1          $2,740.2
       Investments available-for-sale, at
        fair value                                 2,449.9           2,182.8
       Other invested assets, current                 72.8             307.0
       Accrued investment income                     157.2             156.8
       Premiums and self-funded receivables        2,520.2           2,216.4
       Other receivables                           1,172.7             743.7
       Securities lending collateral                 904.7           1,389.9
       Deferred tax assets, net                      642.6             689.0
       Other current assets                        1,284.5           1,022.7
    Total current assets                          11,806.7          11,448.5

    Long-term investments                         15,687.4          15,106.0
    Property and equipment, net                      988.6           1,078.6
    Goodwill                                      13,383.5          13,469.1
    Other intangible assets                        9,396.2           9,686.4
    Other noncurrent assets                          497.4             498.6
    Total assets                                 $51,759.8         $51,287.2

    Liabilities and shareholders' equity
    Liabilities
    Current liabilities:
       Policy liabilities:
         Medical claims payable                   $5,290.3          $4,853.4
         Reserves for future policy benefits          76.3              82.1
         Other policyholder liabilities            2,240.6           1,752.3
       Total policy liabilities                    7,607.2           6,687.8
       Unearned income                               987.9           1,057.1
       Accounts payable and accrued expenses       3,242.2           2,860.4
       Income taxes payable                          538.2             833.4
       Security trades pending payable               124.8             181.8
       Securities lending payable                    904.7           1,389.9
       Current portion of long-term debt             521.0             481.2
       Other current liabilities                   1,397.4           1,286.8
    Total current liabilities                     15,323.4          14,778.4

    Long-term debt, less current portion           6,493.2           6,324.7
    Reserves for future policy benefits,
     noncurrent                                      646.9             679.9
    Deferred tax liability, net                    3,350.2           3,267.1
    Other noncurrent liabilities                   1,370.3           1,244.0
    Total liabilities                             27,184.0          26,294.1

    Shareholders' equity
    Common stock                                       6.1               6.6
    Additional paid-in capital                    19,863.5          20,915.4
    Retained earnings                              4,656.1           4,173.5
    Unearned stock compensation                        -               (82.1)
    Accumulated other comprehensive income (loss)     50.1             (20.3)
    Total shareholders' equity                    24,575.8          24,993.1
    Total liabilities and shareholders' equity   $51,759.8         $51,287.2



                                 WellPoint, Inc.
                     Consolidated Statements of Cash Flows

                                                    Year Ended December 31
    (In millions)                                   2006              2005
                                                (Unaudited)
    Operating activities
    Net income                                    $3,094.9          $2,463.8
    Adjustments to reconcile net income to
     net cash provided by operating activities:
        Net realized losses on investments             0.3              10.2
        Loss on disposal of assets                     1.7               2.7
        Deferred income taxes                        273.7            (102.6)
        Amortization, net of accretion               471.9             437.9
        Depreciation                                 133.0             118.7
        Share-based compensation                     246.9              81.2
        Excess tax benefits from
         share-based compensation                   (136.5)              -
        Changes in operating assets and liabilities,
         net of effect of business combinations:
            Receivables, net                        (649.4)           (230.4)
            Other invested assets, current           234.9               -
            Other assets                            (362.4)           (165.6)
            Policy liabilities                       874.2              46.3
            Unearned income                          (69.5)            (38.2)
            Accounts payable and accrued expenses    (91.7)            188.6
            Other liabilities                        134.2            (136.7)
            Income taxes                            (112.0)            459.6
    Net cash provided by operating activities      4,044.2           3,135.5

    Investing activities
    Purchases of fixed maturity securities       (11,198.0)        (17,457.0)
    Proceeds from sales and maturities of
     fixed maturity securities                    10,351.7          15,735.9
    Purchases of equity securities                (2,434.5)         (4,530.6)
    Proceeds from sales of equity securities       2,950.9           4,480.0
    Changes in securities lending collateral         485.2            (731.4)
    Purchases of subsidiaries, net of
     cash acquired                                   (25.4)         (2,589.7)
    Proceeds from sales of subsidiaries,
     net of cash sold                                  -                92.8
    Purchases of property and equipment             (193.9)           (161.8)
    Proceeds from sales of property and equipment      6.4              10.2
    Other, net                                      (399.7)              -
    Net cash used in investing activities           (457.3)         (5,151.6)

    Financing activities
    Net (repayments of) proceeds from
     commercial paper borrowings                    (306.0)            808.2
    Proceeds from long-term borrowings             2,668.2           1,700.0
    Repayment of long-term borrowings             (2,162.1)           (155.1)
    Changes in securities lending payable           (485.2)            731.4
    Changes in bank overdrafts                       414.3             121.2
    Repurchase and retirement of common stock     (4,550.2)           (333.4)
    Proceeds from exercise of employee stock
     options and employee stock purchase plan        559.5             429.3
    Proceeds from sale of put options                  -                 1.1
    Excess tax benefits from share-based
     compensation                                    136.5               -
    Costs related to issuance of common stock          -                (3.6)
    Net cash (used in) provided by
     financing activities                         (3,725.0)          3,299.1

    Change in cash and cash equivalents             (138.1)          1,283.0
    Cash and cash equivalents at
     beginning of year                             2,740.2           1,457.2
    Cash and cash equivalents at end of year      $2,602.1          $2,740.2



                                 WellPoint, Inc.
                    Reconciliation of Medical Claims Payable

                                                 Year Ended December 31
    (in millions)                              2006       2005        2004
                                            (unaudited)

    Gross medical claims payable,
     beginning of period                    $4,853.4    $4,134.0    $1,836.0
    Ceded medical claims payable,
     beginning of period                       (27.7)      (31.9)       (8.7)
    Net medical claims payable, beginning
     of period                               4,825.7     4,102.1     1,827.3

    Business combinations and purchase
     adjustments                                (6.4)      784.5     2,331.0

    Net incurred medical claims:
        Current year                        42,613.2    32,865.6    15,344.9
        Prior years (redundancies) (1)        (617.7)     (644.9)     (171.9)
    Total net incurred medical claims       41,995.5    32,220.7    15,173.0

    Net payments attributable to:
        Current year medical claims         37,486.0    28,997.1    12,453.2
        Prior years medical claims           4,089.5     3,284.5     2,776.0
    Total net payments                      41,575.5    32,281.6    15,229.2

    Net medical claims payable, end of
     period                                  5,239.3     4,825.7     4,102.1
    Ceded medical claims, end of period         51.0        27.7        31.9
    Gross medical claims payable, end of
     period                                 $5,290.3    $4,853.4    $4,134.0

    Current year medical claims paid as a
     percent of current year net
     incurred medical claims                   88.0%       88.2%     81.2% (2)

    Prior year redundancies in the
     current period as a percent of
     prior year net medical claims payables
     less prior year redundancies in the
     current period                            14.7%       18.7%     10.4%

    Prior year redundancies in the
     current period as a percent of
     prior year net incurred medical claims -
     as reported (3)                            1.9%        4.2%      1.4%

    Prior year redundancies in the
     current period as a percent of
     prior year net incurred medical
     claims - adjusted for acquisitions (3)     1.6%        2.1%      1.4%


    (1) Negative amounts reported for net incurred medical claims related to
        prior years result from claims being settled for amounts less than
        originally estimated.
    (2) This ratio is impacted by having only one month of net incurred
        medical claims and payments for the former WellPoint Health Networks
        Inc. ("WHN") in 2004.  If WHN had not been included in 2004, current
        year medical claims payments would have been $12,057.7 million,
        current year net incurred medical claims would have been $13,835.1
        million and the adjusted ratio would have been 87.2%.
    (3) For all periods presented, except for the year ended December 31,
        2004, the reported ratio of prior year redundancies in the current
        period to prior year net incurred medical claims is impacted by
        certain acquisitions (the former WellChoice, Inc. in 2005 and WHN in
        2004).  The Company has provided ratios adjusted for these
        acquisitions in order to demonstrate these impacts.  Refer to the
        table entitled, "Reconciliation of Medical Claims Payable - Adjusted
        Ratios" for details regarding the respective calculation
        methodologies.



                               WellPoint, Inc.
          Reconciliation of Medical Claims Payable - Adjusted Ratios
                                 (Unaudited)

    Note: Below are reconciliations for the adjusted ratios of prior year
    redundancies in the current period to prior year net incurred medical
    claims that are included in table entitled, "Reconciliation of Medical
    Claims Payable."

    Ratio for the Year Ended December 31, 2006
    This ratio is impacted by having no net incurred medical claims for
     the former WellChoice, Inc. ("WC") in 2005.

        Net incurred medical claims related to prior years
         (redundancies) - year ended December 31, 2006 (As Reported)    $617.7

        Net incurred medical claims - year ended December 31,        $32,865.6
            Ratio (As Reported)                                           1.9%

        Net incurred medical claims - year ended December 31, 2005
         (Comparable Basis) (1)                                      $37,676.0
            Ratio (As Adjusted)                                           1.6%

        (1) Represents comparable benefit expense, assuming WC had been owned
            for the entire year ended December 31, 2005.


    Ratio for the Year Ended December 31, 2005
    This ratio is impacted by having only one month of net incurred medical
     claims for the former WellPoint Health Networks Inc. ("WHN") in 2004.

        Net incurred medical claims related to prior years
         (redundancies) - year ended December 31, 2005 (As Reported)    $644.9

        Net incurred medical claims - year ended December 31,
         2004 (As Reported)                                          $15,344.9
            Ratio (As Reported)                                           4.2%

        Net incurred medical claims - year ended December 31, 2004
         (Comparable Basis) 2                                        $30,819.1
            Ratio (As Adjusted)                                           2.1%

        (2) Represents comparable benefit expense, assuming WHN had been owned
            for the entire year ended December 31, 2004.



                               WellPoint, Inc.
             Selected Financial Data - Comparable Basis Analysis
                                 (Unaudited)


                                As Reported             Comparable Basis (1)
                                Three Months               Three Months
    (In millions)             Ended December 31          Ended December 31
                         2006       2005  % Change    2005   $ Change % Change
    Revenues
    Premiums          $13,293.9  $10,285.2  29.3%  $11,792.6  $1,501.3  12.7%
    Administrative fees   880.7      705.4  24.9%      855.6      25.1   2.9%
    Other revenue         144.5      133.4   8.3%      132.5      12.0   9.1%
        Total operating
         revenue       14,319.1   11,124.0  28.7%   12,780.7   1,538.4  12.0%

    Expenses
    Benefit expense    10,774.9    8,200.3  31.4%    9,506.2   1,268.7  13.3%
    Selling, general and
     administrative
     expense
       Selling expense    424.2      376.5  12.7%      396.2      28.0   7.1%
       General and
        administrative
        expense         1,830.1    1,486.4  23.1%    1,748.7      81.4   4.7%
          Total selling,
           general and
           administrative
           expense      2,254.3    1,862.9  21.0%    2,144.9     109.4   5.1%
    Cost of drugs          68.2       69.5  (1.9%)      69.5      (1.3) (1.9%)

    Benefit expense as a
     percentage of
     premiums             81.1%      79.7%  140 bp     80.6%             50 bp
    Selling, general and
     administrative
     expense as a
     percentage of total
     operating revenue    15.7%      16.7% (100)bp     16.8%           (110)bp


                                As Reported             Comparable Basis (1)
    (In millions)         Year Ended December 31       Year Ended December 31
                         2006       2005  % Change    2005   $ Change % Change
    Revenues
    Premiums          $51,971.9  $40,680.0  27.8%  $46,531.1  $5,440.8  11.7%
    Administrative fees 3,509.6    2,719.2  29.1%    3,325.0     184.6   5.6%
    Other revenue         593.1      519.2  14.2%      518.2      74.9  14.5%
        Total operating
         revenue       56,074.6   43,918.4  27.7%   50,374.3   5,700.3  11.3%

    Expenses
    Benefit expense    42,218.8   32,625.2  29.4%   37,676.0   4,542.8  12.1%
    Selling, general and
     administrative
     expense
       Selling expense  1,654.5    1,474.2  12.2%    1,549.6     104.9   6.8%
       General and
        administrative
        expense         7,163.2    5,798.5  23.5%    6,770.0     393.2   5.8%
          Total selling,
           general and
           administrative
           expense      8,817.7    7,272.7  21.2%    8,319.6     498.1   6.0%
    Cost of drugs         301.2      288.0   4.6%      288.0      13.2   4.6%

    Benefit expense as a
     percentage of
     premiums             81.2%      80.2%  100 bp     81.0%             20 bp
    Selling, general and
     administrative
     expense as a
     percentage of total
     operating revenue    15.7%      16.6%  (90)bp     16.5%            (80)bp


    (1) The "Comparable Basis" information is a non-GAAP measure.  Refer to
        the tables entitled, "Reclassified Consolidated Statements of
        Income - Comparable Basis Reconciliation."



                               WellPoint, Inc.
          Reportable Segment Highlights - Comparable Basis Analysis
                                 (Unaudited)


                                As Reported             Comparable Basis (1)
                                Three Months               Three Months
    (In millions)             Ended December 31          Ended December 31
                         2006       2005  % Change    2005   $ Change % Change
    Operating Revenue
      Health Care
       Segment      $13,766.6  $10,615.6   29.7%  $12,232.7  $1,533.9   12.5%
      Specialty
       Segment          928.9      793.8   17.0%      801.8     127.1   15.9%
      Other Segment    (376.4)    (285.4) (31.9%)    (253.8)   (122.6) (48.3%)
    Total Operating
     Revenue         14,319.1   11,124.0   28.7%   12,780.7   1,538.4   12.0%

    Operating Gain
     (Loss)
      Health Care
       Segment       $1,097.9     $878.5   25.0%     $954.9    $143.0   15.0%
      Specialty
       Segment          143.2      132.8    7.8%      132.8      10.4    7.8%
      Other Segment     (19.4)     (20.0)   3.0%      (27.6)      8.2   29.7%

    Operating Margin (2)
      Health Care
       Segment           8.0%       8.3%   (30)bp      7.8%              20 bp
      Specialty Segment 15.4%      16.7%  (130)bp     16.6%            (120)bp


                                As Reported             Comparable Basis (1)
    (In millions)         Year Ended December 31       Year Ended December 31
                         2006       2005  % Change    2005   $ Change % Change
    Operating Revenue
      Health Care
       Segment      $53,860.6  $41,867.0   28.6%  $48,159.6  $5,701.0   11.8%
      Specialty
       Segment        3,566.2    3,066.1   16.3%    3,098.2     468.0   15.1%
      Other Segment  (1,352.2)  (1,014.7) (33.3%)    (883.5)   (468.7) (53.1%)
    Total Operating
     Revenue         56,074.6   43,918.4   27.7%   50,374.3   5,700.3   11.3%

    Operating Gain
     (Loss)
      Health Care
       Segment       $4,288.3   $3,418.0   25.5%   $3,789.6    $498.7   13.2%
      Specialty
       Segment          523.6      426.4   22.8%      426.9      96.7   22.7%
      Other Segment     (75.0)    (111.9)  33.0%     (125.8)     50.8   40.4%

    Operating Margin (2)
      Health Care
       Segment           8.0%       8.2%   (20)bp      7.9%              10 bp
      Specialty Segment 14.7%      13.9%    80 bp     13.8%              90 bp


    (1) The "Comparable Basis" information is a non-GAAP measure.  Refer to
        the tables entitled, "Reclassified Reportable Segment Highlights -
        Comparable Basis Reconciliation."

    (2) Operating margin is calculated as operating gain as a percentage of
        operating revenue.



                                 WellPoint, Inc.
        Reclassified Consolidated Statements of Income - Comparable Basis
                                 Reconciliation
                                   (Unaudited)


                                          Three Months Ended December 31, 2005
    (In millions)                           WLP (1)  Reclassifica-   WLP (1)
                                          As Reported   tions (2) Reclassified
    Revenues
    Premiums                                $10,410.0    $(124.8)   $10,285.2
    Administrative fees                         707.1       (1.7)       705.4
    Other revenue (expense)                     146.9      (13.5)       133.4
       Total operating revenue               11,264.0     (140.0)    11,124.0
    Net investment income                       179.9        -          179.9
    Net realized (losses) gains on
     investments                                (11.6)       -          (11.6)
    Total revenues                           11,432.3     (140.0)    11,292.3

    Expenses
    Benefit expense                           8,340.3     (140.0)     8,200.3
    Selling, general and administrative
     expense
       Selling expense                          376.5        -          376.5
       General and administrative expense     1,486.4        -        1,486.4
          Total selling, general and
           administrative expense             1,862.9        -        1,862.9
    Cost of drugs                                69.5        -           69.5
    Interest expense                             58.0        -           58.0
    Amortization of other intangible assets      60.2        -           60.2
    Total expenses                           10,390.9     (140.0)    10,250.9

    Income before income taxes                1,041.4        -        1,041.4
    Income taxes                                389.4        -          389.4

    Net income                                 $652.0        $-        $652.0

    Benefit expense as a percentage of
     premiums                                   80.1%                   79.7%
    Selling, general and administrative
     expense as a percentage of total
     operating revenue                          16.5%                   16.7%


                                         Three Months Ended December 31, 2005
                                                                    WellPoint,
                                          WC (1)  Reclass-  WC (1)     Inc.
   (In millions)                            As     ifica-  Reclass- Comparable
                                         Reported tions (2) ified   Basis (3)
    Revenues
    Premiums                             $1,480.5  $26.9  $1,507.4  $11,792.6
    Administrative fees                     139.7   10.5     150.2      855.6
    Other revenue (expense)                  (0.9)   -        (0.9)     132.5
       Total operating revenue            1,619.3   37.4   1,656.7   12,780.7
    Net investment income                    25.2    -        25.2      205.1
    Net realized (losses) gains on
     investments                              0.6    -         0.6      (11.0)
    Total revenues                        1,645.1   37.4   1,682.5   12,974.8

    Expenses
    Benefit expense                       1,283.4   22.5   1,305.9    9,506.2
    Selling, general and administrative
     expense
       Selling expense                        -     19.7      19.7      396.2
       General and administrative
        expense                             267.1   (4.8)    262.3    1,748.7
          Total selling, general and
           administrative expense           267.1   14.9     282.0    2,144.9
    Cost of drugs                             -      -         -         69.5
    Interest expense                          -      -         -         58.0
    Amortization of other intangible
     assets                                   -      -         -         60.2
    Total expenses                        1,550.5   37.4   1,587.9   11,838.8

    Income before income taxes               94.6    -        94.6    1,136.0
    Income taxes                             45.6    -        45.6      435.0

    Net income                              $49.0    $-      $49.0     $701.0

    Benefit expense as a percentage of
     premiums                               86.7%            86.6%      80.6%
    Selling, general and administrative
     expense as a percentage of total
     operating revenue                      16.5%            17.0%      16.8%


    (1) WLP = WellPoint, Inc.; WC = WellChoice, Inc.

    (2) To reflect the reclassification of certain historical amounts to a
        consistent presentation format adopted by the combined organization.
        In connection with the acquisition of WellChoice, Inc., the Company
        adopted a consistent practice for reporting minimum premium amendments
        to fully-insured contracts throughout the combined enterprise.

    (3) The "Comparable Basis" information was calculated by adding the
        reclassified consolidated statements of income for WellPoint, Inc. and
        the former WellChoice, Inc. This "Comparable Basis" information
        contains no intercompany eliminations or pro forma adjustments
        resulting from WellPoint, Inc.'s acquisition of WellChoice, Inc.
        "Comparable Basis" information is presented in order to provide
        investors with a more meaningful comparison to the current period, due
        to the acquisition of WellChoice, Inc. "Comparable Basis" information
        is not calculated in accordance with GAAP and is not intended to
        represent or be indicative of the results that WellPoint, Inc. would
        have reported, had the acquisition been completed as of January 1,
        2005.



                                 WellPoint, Inc.
        Reclassified Consolidated Statements of Income - Comparable Basis
                                 Reconciliation
                                   (Unaudited)


                                              Year Ended December 31, 2005
    (In millions)                            WLP (1)  Reclassifica-  WLP (1)
                                          As Reported   tions (2) Reclassified
    Revenues
    Premiums                                $41,216.7    $(536.7)   $40,680.0
    Administrative fees                       2,729.9      (10.7)     2,719.2
    Other revenue (expense)                     566.5      (47.3)       519.2
       Total operating revenue               44,513.1     (594.7)    43,918.4
    Net investment income                       633.1        -          633.1
    Net realized (losses) gains on
     investments                                (10.2)       -          (10.2)
    Total revenues                           45,136.0     (594.7)    44,541.3

    Expenses
    Benefit expense                          33,219.9     (594.7)    32,625.2
    Selling, general and administrative
     expense
       Selling expense                        1,474.2        -        1,474.2
       General and administrative expense     5,798.5        -        5,798.5
          Total selling, general and
           administrative expense             7,272.7        -        7,272.7
    Cost of drugs                               288.0        -          288.0
    Interest expense                            226.2        -          226.2
    Amortization of other intangible assets     238.9        -          238.9
    Total expenses                           41,245.7     (594.7)    40,651.0

    Income before income taxes                3,890.3        -        3,890.3
    Income taxes                              1,426.5        -        1,426.5

    Net income                               $2,463.8        $-      $2,463.8

    Benefit expense as a percentage of
     premiums                                   80.6%                   80.2%
    Selling, general and administrative
     expense as a percentage of total
     operating revenue                          16.3%                   16.6%


                                             Year Ended December 31, 2005
    (In millions)                                                   WellPoint,
                                         WC (1)  Reclass-  WC (1)      Inc.
                                           As     ifica-  Reclass-  Comparable
                                        Reported tions (2)  ified   Basis (3)
    Revenues
    Premiums                            $5,862.4  $(11.3) $5,851.1  $46,531.1
    Administrative fees                    561.5    44.3     605.8    3,325.0
    Other revenue (expense)                 (1.0)    -        (1.0)     518.2
       Total operating revenue           6,422.9    33.0   6,455.9   50,374.3
    Net investment income                   85.6     -        85.6      718.7
    Net realized (losses) gains on
     investments                             4.8     -         4.8       (5.4)
    Total revenues                       6,513.3    33.0   6,546.3   51,087.6

    Expenses
    Benefit expense                      5,078.4   (27.6)  5,050.8   37,676.0
    Selling, general and
     administrative expense
       Selling expense                       -      75.4      75.4    1,549.6
       General and administrative
        expense                            986.3   (14.8)    971.5    6,770.0
          Total selling, general and
           administrative expense          986.3    60.6   1,046.9    8,319.6
    Cost of drugs                            -       -         -        288.0
    Interest expense                         -       -         -        226.2
    Amortization of other intangible
     assets                                  -       -         -        238.9
    Total expenses                       6,064.7    33.0   6,097.7   46,748.7

    Income before income taxes             448.6     -       448.6    4,338.9
    Income taxes                           178.4     -       178.4    1,604.9

    Net income                            $270.2     $-     $270.2   $2,734.0

    Benefit expense as a percentage of
     premiums                              86.6%             86.3%      81.0%
    Selling, general and administrative
     expense as a percentage of total
     operating revenue                     15.4%             16.2%      16.5%


    (1) WLP = WellPoint, Inc.; WC = WellChoice, Inc.

    (2) To reflect the reclassification of certain historical amounts to a
        consistent presentation format adopted by the combined organization.
        In connection with the acquisition of WellChoice, Inc., the Company
        adopted a consistent practice for reporting minimum premium amendments
        to fully-insured contracts throughout the combined enterprise.

    (3) The "Comparable Basis" information was calculated by adding the
        reclassified consolidated statements of income for WellPoint, Inc. and
        the former WellChoice, Inc. This "Comparable Basis" information
        contains no intercompany eliminations or pro forma adjustments
        resulting from WellPoint, Inc.'s acquisition of WellChoice, Inc.
        "Comparable Basis" information is presented in order to provide
        investors with a more meaningful comparison to the current period, due
        to the acquisition of WellChoice, Inc. "Comparable Basis" information
        is not calculated in accordance with GAAP and is not intended to
        represent or be indicative of the results that WellPoint, Inc. would
        have reported, had the acquisition been completed as of January 1,
        2005.



                                 WellPoint, Inc.
          Reclassified Reportable Segment Highlights - Comparable Basis
                                 Reconciliation
                                   (Unaudited)


                                          Three Months Ended December 31, 2005
    (In millions)                            WLP (1)  Reclassifica-   WLP (1)
                                          As Reported   tions (2) Reclassified
    Operating Revenue (4)
    Health Care                             $10,782.8    $(167.2)   $10,615.6
    Specialty                                   748.7       45.1        793.8
    Other                                      (267.5)     (17.9)      (285.4)
    Commercial Managed Care                       -          -            -
    Other Insurance Products and Services         -          -            -
       Total operating revenue               11,264.0     (140.0)    11,124.0

    Operating Gain (Loss) (4)
    Health Care                                 896.2      (17.7)       878.5
    Specialty                                   115.1       17.7        132.8
    Other                                       (20.0)       -          (20.0)
    Commercial Managed Care                       -          -            -
    Other Insurance Products and Services         -          -            -



                                      Three Months Ended December 31, 2005
    (In millions)                                                  WellPoint,
                                      WC (1)   Reclass-   WC (1)      Inc.
                                        As      ifica-   Reclass-  Comparable
                                     Reported  tions (2)  ified     Basis (3)
    Operating Revenue (4)
    Health Care                           $-   $1,617.1  $1,617.1  $12,232.7
    Specialty                              -        8.0       8.0      801.8
    Other                                  -       31.6      31.6     (253.8)
    Commercial Managed Care           1,398.9  (1,398.9)      -          -
    Other Insurance Products and
     Services                           220.4    (220.4)      -          -
       Total operating revenue        1,619.3      37.4   1,656.7   12,780.7

    Operating Gain (Loss) (4)
    Health Care                           -        76.4      76.4      954.9
    Specialty                             -         -         -        132.8
    Other                                 -        (7.6)     (7.6)     (27.6)
    Commercial Managed Care              95.1     (95.1)      -          -
    Other Insurance Products and
     Services                           (26.3)     26.3       -          -


                                             Year Ended December 31, 2005
    (In millions)
                                             WLP (1)  Reclassifica-  WLP (1)
                                          As Reported   tions (2) Reclassified
    Operating Revenue (4)
    Health Care                             $42,597.5    $(730.5)   $41,867.0
    Specialty                                 2,863.1      203.0      3,066.1
    Other                                      (947.5)     (67.2)    (1,014.7)
    Commercial Managed Care                       -          -            -
    Other Insurance Products and Services         -          -            -
       Total operating revenue               44,513.1     (594.7)    43,918.4

    Operating Gain (Loss) (4)
    Health Care                               3,459.0      (41.0)     3,418.0
    Specialty                                   388.1       38.3        426.4
    Other                                      (114.6)       2.7       (111.9)
    Commercial Managed Care                       -          -            -
    Other Insurance Products and Services         -          -            -



                                             Year Ended December 31, 2005

    (In millions                                                    WellPoint,
                                       WC (1)   Reclass-   WC (1)      Inc.
                                         As      ifica-   Reclass-  Comparable
                                      Reported  tions (2)  ified     Basis (3)
    Operating Revenue (4)
    Health Care                           $-   $6,292.6  $6,292.6  $48,159.6
    Specialty                              -       32.1      32.1    3,098.2
    Other                                  -      131.2     131.2     (883.5)
    Commercial Managed Care           5,530.7  (5,530.7)      -          -
    Other Insurance Products and
     Services                           892.2    (892.2)      -          -
       Total operating revenue        6,422.9      33.0   6,455.9   50,374.3

    Operating Gain (Loss) (4)
    Health Care                           -       371.6     371.6    3,789.6
    Specialty                             -         0.5       0.5      426.9
    Other                                 -       (13.9)    (13.9)    (125.8)
    Commercial Managed Care             331.5    (331.5)      -          -
    Other Insurance Products and
     Services                            26.7     (26.7)      -          -


    (1) WLP = WellPoint, Inc.; WC = WellChoice, Inc.

    (2) To reflect the reclassification of certain historical amounts to a
        consistent presentation format adopted by the combined organization.
        In connection with the acquisition of WellChoice, Inc., the Company
        adopted a consistent practice for reporting minimum premium amendments
        to fully-insured contracts throughout the combined enterprise.

    (3) The "Comparable Basis" information was calculated by adding the
        reclassified consolidated statements of income for WellPoint, Inc. and
        the former WellChoice, Inc. This "Comparable Basis" information
        contains no intercompany eliminations or pro forma adjustments
        resulting from WellPoint, Inc.'s acquisition of WellChoice, Inc.
        "Comparable Basis" information is presented in order to provide
        investors with a more meaningful comparison to the current period, due
        to the acquisition of WellChoice, Inc. "Comparable Basis" information
        is not calculated in accordance with GAAP and is not intended to
        represent or be indicative of the results that WellPoint, Inc. would
        have reported, had the acquisition been completed as of January 1,
        2005.

    (4) Operating revenue and operating gain are the key measures used by
        management to evaluate performance in each segment.  Operating gain is
        defined as operating revenue less benefit expense, selling expense,
        general and administrative expense, and cost of drugs.  Operating gain
        is used to analyze profit or loss on a segment basis. Consolidated
        operating gain is a non-GAAP measure.

SOURCE WellPoint, Inc.

CONTACT: Investor Relations, Wayne DeVeydt, +1-317-488-6390, or Media, Jim Kappel, +1-317-488-6400, both of WellPoint, Inc.

Twitter Anthem YouTube